Nexstim Plc
NXTMH.HE

$36.57 M
Marketcap
$5.40
Share price
Country
$-0.08
Change (1 day)
$7.12
Year High
$2.20
Year Low
Categories

Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.

marketcap

Revenue of Nexstim Plc (NXTMH.HE)

Revenue in 2023 (TTM): $7.59 M

According to Nexstim Plc's latest financial reports the company's current revenue (TTM) is $7.59 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Nexstim Plc

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $7.59 M $2.42 M $-979,896 $-1,385,444 $-1,390,506
2022 $9.98 M $9.97 M $1.69 M $1.37 M $1.37 M
2021 $6.7 M $6.52 M $882.63 K $-768,047 $-871,589
2020 $4.31 M $3.29 M $-1,108,272 $-4,311,971 $-4,317,184
2019 $3.51 M $2.41 M $-4,968,695 $-7,098,477 $-7,104,472
2018 $2.8 M $1.72 M $-5,309,142 $-6,444,530 $-6,446,338
2017 $2.77 M $643.33 K $-5,499,379 $-7,672,694 $-7,675,632
2016 $2.6 M $698.44 K $-6,623,661 $-7,049,762 $-7,052,169
2015 $2.65 M $-2,040,045 $-8,434,945 $-10,291,815 $-10,293,264
2014 $2.32 M $-517,475 $-7,430,995 $-10,941,024 $-10,941,024
2013 $1.96 M $1.3 M $-4,395,748 $-4,729,169 $-4,729,169
2012 $3.34 M $2.56 M $-2,421,485 $-2,827,027 $-2,827,027